Cinemark Holdings, Inc. (CNK): Director bought ~$164K
Mark Zoradi, Director at Cinemark Holdings, Inc., bought ~$164K of Cinemark Holdings, Inc. shares.
- ~$164K
- Approx. value · 5,000 sh @ $32.83
- 8,920
- Holds after · shares reported
- Traded
- Aug 28, 2017
- Filed
- Dec 22, 2025
What stands out in this filing
- The first open-market purchase by any CNK insider since Mar 2008.
- Mark Zoradi's first open-market purchase of CNK in filings since 2007.
- The purchase added 127.6% to the shares this insider held before it; the filing reports 8,920 shares, held indirectly afterwards.
- 5,000 shares at an average of $32.83 each, as reported on the form.
Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Cinemark Holdings, Inc.
For Cinemark Holdings, Inc., OQRO holds 1 fund holdings report (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CNK page.
Other recent filings by Mark Zoradi, Director
- SEC Form 4 at Cinemark Holdings, Inc. (CNK)May 4, 2026
- SEC Form 4 at Cinemark Holdings, Inc. (CNK)Dec 22, 2025
- SEC Form 4 at Cinemark Holdings, Inc. (CNK)Dec 22, 2025
- SEC Form 4 at Cinemark Holdings, Inc. (CNK)Dec 22, 2025
- SEC Form 4 at Cinemark Holdings, Inc. (CNK)Dec 22, 2025
The full history of Mark Zoradi, Director is on the profile page.
How this filing works
Explore the data
Common questions
Which Cinemark Holdings, Inc. (CNK) insider traded, and how much?
Mark Zoradi, Director at Cinemark Holdings, Inc., bought ~$164K of Cinemark Holdings, Inc. shares. 5,000 shares at $32.83, open market.
When did it happen, and when was it made public?
Traded: Aug 28, 2017. Filed: Dec 22, 2025. That is 3038 days between the two dates.
What stands out in this filing?
The first open-market purchase by any CNK insider since Mar 2008. Mark Zoradi's first open-market purchase of CNK in filings since 2007. The purchase added 127.6% to the shares this insider held before it; the filing reports 8,920 shares, held indirectly afterwards.
Is the dollar amount exact?
It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.
Where does this information come from?
From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Cinemark Holdings, Inc. recently?
For Cinemark Holdings, Inc., OQRO holds 1 fund holdings report (13F) dated in the last 90 days. They are listed on the CNK page.
Does this mean CNK stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Cinemark Holdings, Inc.
- SEC Form 13F-HRNov 16, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 4May 4, 2026
- SEC Form 13F-HRFeb 17, 2026
- SEC Form 13F-HRFeb 17, 2026
Everything OQRO holds on this company is on its CNK page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
